Multidrug-resistant Salmonella associated with AmpC hyperproduction

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1348-

  Horton, James M ^a   Sing, Ronald F ^a   Jenkins, Stephen G ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN; SULTAMICILLIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CASE REPORT; CHOLEDOCHOJEJUNOSTOMY; COMMON BILE DUCT CYST; FEMALE; HUMAN; HYPOTENSION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SURGICAL DRAINAGE; TACHYCARDIA;

EID: 0033503139     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313476     Document Type: Article

References (3)

1. 1. Gaillot O, Clement C, Simonet M, Philippon A. Novel transferable betalactam resistance with cephalosporinase characteristies in Salmonella enteritidis. J Antimicrob Chemother 1997;39:85-7.
2. 2. Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH, Philippon A. Salmonella enteritidis: AmpC plasmid-mediated beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 1998;42:2352-8.
3. 3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 8th international supplement. NCCLS document M100-S8, Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1998:11.